Works matching AU Yumita, Sae

Results: 13
    1

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    2

    Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 291, doi. 10.1111/hepr.14088
    By:
    • Ozaki, Tomomi;
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Yoshino, Ryohei;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Miwa, Chihiro;
    • Yonemoto, Takuya;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato
    Publication type:
    Article
    3

    Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02731-5
    By:
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Nakagawa, Miyuki;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kogure, Tadayoshi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke
    Publication type:
    Article
    4

    Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02674-x
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Yumita, Sae;
    • Iwanaga, Terunao;
    • Unozawa, Hidemi;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Inoue, Masanori;
    • Kiyono, Soichiro
    Publication type:
    Article
    5
    6

    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
    By:
    • Nakagawa, Miyuki;
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kikuchi, Yasuharu;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta
    Publication type:
    Article
    7

    Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 6, p. 515, doi. 10.1007/s00535-024-02097-9
    By:
    • Fujiwara, Kisako;
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Tsuchiya, Satoshi;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Koizumi, Jun
    Publication type:
    Article
    8

    Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 286, doi. 10.1159/000542577
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Izai, Ryo;
    • Yonemoto, Takuya;
    • Akatsuka, Teppei;
    • Miwa, Chihiro;
    • Yumita, Sae;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nakada, Shinichiro;
    • Sakai, Nozomu;
    • Yokoyama, Masayuki;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    9

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article
    10

    Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
    By:
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Yoshino, Ryohei;
    • Fujimoto, Kentaro;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    11

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    12

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    13

    Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38377-2
    By:
    • Kondo, Takayuki;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Kato, Naoya
    Publication type:
    Article